Biological effect of PCBs, PCQs and PCDFs present in the oil causing yusho and yu-cheng. by Kunita, N et al.
Environmental Health Perspectives
Vol. 59, pp. 79-84, 1985
Biological Effect of PCBs, PCQs and
PCDFs Present in the Oil Causing Yusho
and Yu-Cheng
by Nobuharu Kunita,* Shinjiro Hori,* Hirotaka Obana,*
Toru Otake,* Hiroshi Nishimura,* Takashi Kashimoto*
and Nobuko Ikegamit
Male Sprague-Dawley rats were daily given orally for 22 days a regimen consisting of polychlori-
nated biphenyls (PCBs), 1 mg/day; polychlorinated quaterphenyls (PCQs), 1 mg/day; polychlorinated
dibenzofurans (PCDFs), 10 ,ug/day; or a mixture of PCBs, PCQs and PCDFs (Mix-1, 1 mg + 1 mg +
10 ,ug/day).
Female Cynomolgus monkeys were daily administered PCBs (5 mg), PCQs (5 mg) or a mixture
(Mix-2) containing 5 mg PCBs + 20 ,ug PCDFs for 20 weeks. The PCBs, and PCDFs had the components
of PCBs, PCQs and PCDFs similar to those contained in Japanese Yusho oils, respectively.
The PCB-treated rats and monkeys showed hepatic hypertrophy, immunosuppression and increased
drug-metabolizing enzyme activities in hepatic microsomes, but were devoid of the dermal symptoms
characteristic of Yusho. PCQs caused an increase in drug-metabolizing enzyme activities in hepatic
microsomes and immunosuppression in monkeys, but these effects were much smaller than those
found with PCBs treatment.
On the other hand, treatment with PCDF or Mix-1 or Mix-2 caused hypertrophy of the liver,
immunosuppression, increase in drug-metabolizing enzyme activities of hepatic microsome to much
greater extent than observed with PCBs, being more than 100 times as effective as PCBs. In addition
PCDFs and the mixtures containing PCDFs caused weight loss and thymic atrophy.
PCDFs and Mix-2-treated monkeys showed the dermal symptoms that are characteristic of Yusho
patients but were not observed in monkeys treated with PCBs and PCQs alone. These results suggest
that PCDFs are the primary causative agent of Yusho.
Introduction
Yushois acomplicatedpolychlorinatedbiphenyl(PCB)
poisoning (1), since PCBs, which have beenregarded as
the principal causative substance ofthis poisoning, are
composed of a number of isomers of different nature,
and since the toxic rice oil causing Yusho contains, in
addition, polychlorinated quaterphenyls (PCQs) (2) and
highlytoxicpolychlorinated dibenzofurans (PCDFs) (3).
Recently, it has been found that PCB isomers vary
greatly in toxicity (4-6). Moreover, PCQs (7) and
PCDFs (8) have been detected in samples of blood and
some organs of patients with Yusho.
Therefore, to understand the nature of the chemical
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substances responsible for Yusho, PCB, PCQ and
PCDF samples resembling in composition the PCBs,
PCQs and PCDFs found in the toxic rice oil were
prepared in our laboratory by distilling KC-400 under
reduced pressure. The present paper reports an exper-
imental study ofthe toxicity ofthese PCBs, PCQs and
PCDFs to rats and monkeys and presents a possible
interpretation of human intoxication by the polychlori-
nated compounds.
Experimental
Rats
Male Sprague-Dawley rats (5 weeks old, weighing
about 150g) were raised in stainless-steel cages without
bedding in an air-conditioned room with water and rat
chow (Oriental Yeast Co. Ltd., Japan) ad libitum.KUNITA ET AL.
For oral administration, the PCBs, PCQs, PCDFs or
Mix-1 were dissolved in olive oil. The daily dose ofeach
sample ofPCBs, PCQs, PCDFs or mix is listed in Table
1. All rats were observed daily for evidence of changes
in demeanor and appearance. Body weights were re-
corded daily during treatment and thereafter. Each
group was divided into five subgroups of six each and
sacrificed at 5, 10 and 22 days of treatment and 10 and
24 days after cessation of treatment.
Monkeys
Ten female Cynomolugus monkeys (Macacafascicu-
lanrs) weighing approximately 2.5 kg were obtained
from Malaya, and reared for 3 months in individual
cages in air-conditioned rooms before starting experi-
ments. During the 20-week experimental period, mon-
keys were daily fed bread (30 g), monkey chow (100 g,
Oriental Yeast Co., Japan) and bananas (50 g), and were
given water ad libitum.
For oral administration, the PCBs, PCQs, PCDFs
and Mix-2 were dissolved in olive oil, and the daily dose
(Table 1) was injected into apiece ofbanana (50 g) given
to the monkeys once a day, except Sundays, for 20
weeks.
The monkeys were observed daily for physical and
clinical signs, and were weighed and bled at 4-week
intervals throughout the experimental feeding period.
Finally they were examined by autopsy for pathologic
changes in their internal organs. The monkeys fed
PCDFs (Nos. 4, 5 and 6) were killed inweek 16, because
they appeared to be close to death.
Chemicals
KC-400 and PY-PCQs were obtained from Kanegafu-
chi Chemical Ind. Co. (Kyogo, Japan).
PY-PCBs and PY-PCDFs were prepared from a
KC-400 as described in Table 1 and the previous report
(9).
PY-PCBs, PY-PCQs and PY-PCDFs had composition
of PCBs, PCQs and PCDFs similar to those contained
in the Japanese toxic rice oils. Mixture 1 (abbreviated
Mix-1) was a complex mixture of PY-PCBs, PY-PCQs
and PY-PCDFs in proportions of 1:1:0.01 (the approxi-
mate proportion of these compounds in toxic rice oil),
and Mixtures 2 (abbreviated Mix-2) was a complex of
PY-PCBs and PY-PCDFs, 1:0.0004.
Immunization and Assay for Anti-Sheep
Red Blood Cell (SRBC) Antibodies
All rats ormonkeys were immunized three times with
0.5 mL and 1.5 mL of10% SRBC in physiological saline.
Blood samples were collected 12 days aftereach immuni-
cation. Serum samples were stored at - 20°C until as-
sayed for anti-SRBC antibody and immunoglobulin
(IgG) levels.
The hemolysin titer was measured by 100% hemolysis
method (10). The quantitation of IgG was carried out
according to the method described by Otake et al. (11).
Enzyme Assays
Microsomal protein concentration was measured ac-
cording to the method of Lowry et al. (12). Cytochrome
P-450 content was determined by the method of Omura
and Sato (13). Microsomal N-demethylation ofaminopy-
rineand O-demethylation ofp-nitroanisole and NADPH-
cytochrome c reductase were quantified by the method
described the previous report (14). Benzo(a)pyrene
hydroxylase activity was measured by the method of
Nebert and Gelboin (15).
Table 1. Experimental groups.
Daily dose fed Feeding
Animal Compounds per animal periods
Ratsa PY-PCBsb 1 mg 22 days
PY-PCQsc 1 mg 22 days
PY-PCDFsd 10 jig 22 days
Mix-1 (PY-PCBs + PY-PCQs + PY-PCDFs)e 1 mg + 1 mg + 10 ,ug 22 days
None (control) 22 days
Monkeys'
No. 1 PY-PCBs 5 mg 20 weeks
Nos. 2,3 PY-PCQs 5 mg 20 weeks
Nos. 4,5,6 PY-PCDFs 20 ,ug 16 weeksg
Nos. 7 Mix-2h 5 mg 20 weeks
Nos. 8,9,10 None (control) 20 weeks
aMale Sprague-Dawley rats (5 weeks old); six rats per group.
bPY-PCBs were prepared from KC-400 by distillation under reduced pressure; PCDFs and PCQs were removed by Florisil column
chromatography. Thecomposition ofPCBsinthePY-PCBs is similartothat ofthe PCB-contaminated Kanemirice oilsample which caused Yusho
(toxic rice oil).
cThe composition of PCQ in the PY-PCQs is similar to that of the PCQ-contaminated toxic rice oil.
dPY-PCDFs were prepared from KC-400 by distillation under reduced pressure and PCBs and PCQs were removed by Florisil column
chromatography. The composition of PCDF in the PY-PCDFs is similar to that of the PCDF-contaminated toxic rice oil.
eMix-1 is similar to the proportions of PCBs, PCQs and PCDFs in the toxic rice oil.
'Female Cynomolgus monkeys weighing approximately 2.5 kg.
gMonkeys 4, 5, and 6 became moribund and were killed on week 16 of feeding.
hMix-2 is the PY-PCBs with PCDFs of 400 ppm.
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Results
Rat
The inhibition of the increase in body weight was
noted only in the PY-PCDFs group and Mix-1 group
with PY-PCDFs. The tendency continued also following
discontinuance of administration.
Changes in the weight ratios ofthe organs were noted
for the liver and the thymus: namely, the ratio for the
liver increased in each group except for the PY-PCQs
group, especially in the Mix-1 group. On the other hand,
marked atrophy of the thymus was noted in the PY-
PCDFs group and Mix-1 group. This atrophy was still
observed on the day 24 after administration was
discontinued.
The PY-PCBs group showed increased alkaline phos-
phatase (AlP), glutamicoxaloacetictransaminase (GOT)
and cholesterol levels. By contrast, the Mix-1 group (a
toxic rice oil minic) showed a significant decrease in
glutamic pyruvic transaminase (GPT) and a significant
increase in cholesterol level. The groups administered
PCBs, PCQs and PCDFs showed no significant increase
in triglycerides, a value which was reported to increase
in Yusho patients, but the Mix-1 group showed a
significant increase in that value.
Rats ofeach group were immunized three times with
SBRC and 12 days after each challenge their ability to
produce anti-SRBC antibody and blood IgG level was
determined. The suppression of the anti-SRBC anti-
body production was seen on day 22 ofadministration in
the groups of Mix-1, PY-PCBs and PY-PCDFs, among
which the Mix-1 group showed the most marked
suppression. Blood IgG level and leukocytes also tended
to decrease. In addition the suppression was still noted
even on day 24 after discontinuance ofadministration of
the toxic oil components. On the contrary, the PY-PCQs
group scarcely exhibited suppression ofthe anti-SRBC
antibody production (Fig. 1).
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FIGURE 2. Comparative effects of pretreatment with PY-PCBs,
PY-PCQs, PY-PCDFs and Mix-i on liver enzyme activities in rats.
PY-PCBs (1 mg/day), PY-PCQs (1 mg/day), PY-PCDFs (10 ,ug/day)
or Mix-1 (PY-PCBs 1 mg + PY-PCQs 1 mg + PY-PCDFs 10
,ug/day) were given orally to each rat.
Figure 2 shows the activities of induction of hepatic
microsomaldrugmetabolizingenzymes. PCBsincreased
the activityofcytochrome P-450, p-nitroanisole O-deme-
thylase, aminopyrine N-demethylase and benzo(a) py-
rene hydroxylase. The pattern ofthe enzyme induction
showed a mixture ofphenobarbital (PB)- and 3-methyl-
cholanthrene (MC)-types, in good agreement with the
observed shift ofthe absorption maximum to 449 nm in
the CO-difference spectra. The enzyme-inducing ability
ofPCQs was weaker than that ofother test substances
and showed a mixed-type induction of PB and MC.
PCDFs strongly induced benzo(a)pyrene hydroxylase,
showing MC-type induction, whereas Mix-1 showed
strong inducing effects upon all the enzymes.
The effects of PCQs on rats were far weaker than
those of PCBs. PCDFs, however, had intensive effects
on rats, despite the fact that the dose was only
one-hundredth that of PY-PCBs or PY-PCQs. In other
words, the toxicity of PY-PCDFs in rats is 100 times
that ofPCBs or PCQs. However, even with PCDFs and
Mix-i it was not possible to evoke cutaneous symptoms
such as the dermal acneform lesions characteristic of
Yusho.
Therefore, we studied the influence of Yusho-related
compounds on female monkeys which were assumed to
be more susceptible toPCBs than rats and attempted to
reproduce Yusho symptoms in these animals.
FIGURE 1. Effects of PY-PCBs, PY-PCQs, PY-PCDFs and Mix-i on
hemolysin titer ofrats. Rats were immunized three times with 0.5
mL of 10% SRBC in physiological saline and blood samples were
collected 12 days after each immunization. PY-PCBs (1 mg/day),
PY-PCQs (1 mg/day), PY-PCDFs (10 jig/day) or Mix-1 (PY-PCBs 1
mg + PY-PCQs 1 mg + PY-PCDFs 10jig/day) were given orallyto
each rat.
Monkey
Monkeys treated with Mix-2 and PCDFs showed a
decrease in body weight; approximately a 15% decrease
in both groups 12 weeks after the beginning of the
experiment. The food consumption of these monkeys
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during the experimental perod was not different from
that of the monkeys fed PCBs, PCQs and control
monkeys. The monkeys on PCBs and PCQs kept the
initial body weight or had a slight weight gain.
Figure 3 shows the organweight perunitbodyweight
of monkeys and activities of hepatic drug-metabolizing
enzymes. Among the organs tested, liver was the most
profoundly influenced by the test substances. The
Mix-2-treated monkey showed markedly increased liver
weight, about 2.4 times that of control monkeys, and
also showed hypertrophy ofkidney and spleen. Further,
PCDF-treated monkeys showed greater hypertrophy
of spleen than was found in other test animals.
As shown in Figure 3, activities ofcytochrome P-450,
benzo(a)pyrene hydroxylase and aminopyrine N-deme-
thylase increased in all the monkeys except PCDF-
treated monkeys. In particular, this tendency was the
most marked with the Mix-2 animal. In contrast, in
monkeys fed PCDFs, the activities of cytochrome
P-450, aminopyrineN-demethylase, and benzo(a)pyrene
hydroxylase were 80, 50 and 50%, respectively, ofthose
of the control monkeys. We consider the observed low
enzymatic activities of PCDF-treated monkeys were
due to the extreme asthenia of these monkeys at the
time of dissection.
On immunological study, Mix-2 and PY-PCB-treated
monkeys showed marked suppression of anti-SRBC
antibody production, the antibody titer being less than
5 before the second immuization. The monkey fed PCBs
(without PCDFs) showed increased antibody produc-
tion after the second immunization, while administra-
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FIGURE 3. Comparative effects of pretreatment with PY-PCBs,
POY-PCQs, PY-PCDFs and Mix-2 on liver enzyme activities and
organ weights in monkeys. PY-PCBs (5 mg/day), PY-PCQs (5
mg/day) or Mix-2 (5 mg/day) were given orally for 20 weeks.
PY-PCDFs (20 Fg/day) were given orally for 16 weeks.
tion of Mix-2 (with PCDFs) caused suppression of
antibody-producing abilitythroughout the experimental
period (Fig. 4). Further, in contrast to monkeys treated
with PY-PCBs, PY-PCDF-treated monkeys showed con-
tinuous decrease in antibody production with time,
reaching about the same extent of suppression after 16
weeks as that ofMix-2-treated monkey. PCQs were also
found to suppress antibody-producing ability (Fig. 4).
Monkeys treated with PY-PCDFs or Mix-2 (with
PCDF) showed hair loss, periorbital edema, Meibomian
retention cysts, and acneforms lesions on faces-all
characteristic symptoms of Yusho disease. Further,
thesemonkeysshowedtheenlargementofhyperkeratino-
sis of pilar pores, and the degeneration of hair root on
the dorsal skin.
In contrast, the control monkeys and those treated
with PY-PCBs or PY-PCQs did not show any of the
clinical symptoms characteristic of Yusho as were
observed in monkeys treated with PY-PCDFs and Mix-2
(with PCDFs).
Discussion
It is well known that PCBs have a strong inducing
effect on the drug-metabolizing enzymes of hepatic
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FIGURE 4. Effects of PY-PCBs, PY-PCQs, PY-PCDFs and Mix-2
feedingonanti-SRBC antibody. Monkeyswereimmunizedwith 1.5
mL of 10% SRBC in physiological saline on days 16, 44 and 72 of
feeding. The blood samples were collected 12 days after each
immunization. PY-PCBs (5 mg/day), PY-PCQs (5 mg/day) or Mix-2
(5 mg/day) were given orally for20 weeks. PY-PCDFs (20 ,ug/day)
were given orally for 16 weeks.
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microsomes (16,17), and Kanechlor and other PCB
products are mixtures of phenobarbital (PB) and 3-
methylcholanthrene (MC) type PCBs (16). Recently,
Yoshimura et al. (4) demonstrated that MC-type PCBs
exhibited marked toxic effects that PB-type PCBs did
not share: hypertrophy of liver and atrophy ofthymus.
They also clearly showed a positive correlation between
the ability of MC-type PCBs to induce activity of liver
enzymes and toxicity. The present study revealed that
PY-PCBs, which have similar composition to the PCBs
in the toxic rice oil, have mixed type inducingability, as
isthe case with commercialPCB products. The enzyme-
inducing ability of PY-PCBs is stronger than that of
KC-400 as judged by our experiments with KC-400
administered to rats (unpublished data) and monkeys
(9,14). PY-PCQs, which have similar composition to
PCQs in the toxic rice oil, also caused enzyme induction
of the same type as PY-PCBs, but to a much smaller
extent. On the other hand, PY-PCDFs and mixtures
containing PCDFs (Mix-1 and Mix-2) caused MC-type
enzyme induction and further brought about decrease
in body weight and marked atrophy of thymus which
were not observed in PY-PCB- or PY-PCQ-treated
animals. These results are cons"istent with the report of
Yoshimura et al. (4) described above.
Loose et al. (18) reported that administration of
Aroclor to mice caused a decrease in anti-SRBC
antibody-producing ability and serum IgG level. The
present study demonstrates the suppression ofimmune
system in PY-PCB-treated rats and monkeys, in agree-
ment with the report of Loose (18) and Thomas (19).
The fact that PY-PCQ-treated monkey showed suppres-
sion of anti-SRBC antibody-producing ability that was
not observed in similarly treated rats indicates that
monkeys are highly susceptible to these organochlorine
compounds. Administration to rats and monkeys of
PY-PCDFs of composition analogous to that of PCDFs
in the toxic rice oil produced more marked immunosup-
pression than PY-PCBs, in spite of the 100-fold differ-
ence in amount administered.
As demonstrated above, PY-PCDFs and Mix-i exhib-
ited marked effects on rats with respect to body weight
increase, immunosuppression, enzyme induction, and
blood biochemical finding, but the dermal symptoms
characteristic of Yusho patients could not be observed.
However, administration of PY-PCDFs and Mix-2 to
monkeysmadeitpossibletoreproduceYushosymptoms.
Thus, administration ofPY-PCBs or PY-PCQs alone to
monkeys did not cause Yusho symptoms. These results
indicate that PCDFs are the compounds responsible for
the developoment of Yusho symptoms.
In our experiments, the calculated doses ofPY-PCBs
and PY-PCDFs required for the induction ofthe dermal
symptomsinmonkey fed Mix-2, as converted tothe dose
per average human body weight (50 kg), were 600 mg
and 2.4 mg. Hayabuchi et al. (20) who investigated the
biochemical aspects, estimated the critical doses as 466
mgforPCBs, 439 mgfor PCQs, and 2.5 mg for PCDFs,
which values agree quite well with the data from
monkeys. Further, even administration of PY-PCDFs
alone caused Yusho symptoms, while administration to
monkeys of PY-PCBs or PY-PCQs which contained no
PCDFs did not cause Yusho symptoms even at a dose
approximately 13 times the dose ingested by Yusho
patients.
Hara et al. (21) and other investigators (22) reported
that the clinical symptoms of patients occupationally
exposed to PCBs were much milder than those ofYusho
patients, and the blood PCB composition ofthe former
patients was clearly different from that of Yusho
patients. Further, Yu-Cheng patients of Taiwan show
much graver symptoms than the patients occupationally
exposed toPCBs, in spite ofthe factthattheblood PCB
level of the former is less than or at most in the same
range as that of the latter (22,23).
The present study with monkeys clearly indicates
that the observed differences between the symptoms of
the patients occupationally exposed to PCBs and Yusho
patients are due not to a difference in the composition
between commercial PCB products and toxic rice oil,
but to the presence of PCDFs in the toxic rice oil and
suggests that PCDFs are the primary causative agents
of Yusho.
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